Funder: DARPA - Biological Technologies Office
Due Dates: September 19, 2024 (Updated Response Date) | September 20, 2024 (Updated Inactive Date)
Funding Amounts: Funding details not specified; supports cooperative agreements for high-risk, high-reward biological technology research.
Summary: This amendment extends proposal submission deadlines for DARPA BTO’s Office-Wide Broad Agency Announcement focused on innovative biological technologies.
Key Information: The Biological Technologies Office targets breakthrough research at the intersection of biology, engineering, and computer science with applications for national security.
The Biological Technologies Office (BTO) of DARPA has issued Amendment 1 to its Office-Wide Broad Agency Announcement (BAA) HR001123S0045, which extends the deadlines for submitting proposal abstracts and full proposals, as well as the overall BAA closing date. This BAA supports research projects that push the boundaries of biological technologies, particularly those that integrate biology with engineering and computer science to develop revolutionary solutions for military and dual-use applications.
DARPA BTO focuses on high-risk, high-reward research in areas such as biosecurity, synthetic biology, neurotechnology, and human performance optimization. The office aims to fund projects that could transform military medicine, enhance warfighter capabilities, and create novel biological sensors or threat detection methods.
This amendment does not specify funding amounts but indicates cooperative agreements as the funding mechanism. Researchers interested in submitting proposals should note the updated deadlines and review the full BAA documents for detailed requirements and scope.
| Contact Role | Details |
|---|---|
| BAA Coordinator | BTOBAA2023@darpa.mil |
| General Contact | Phone: (703) 526-6630 |
| DARPA BTO Address | 675 North Randolph Street, Arlington, VA 22203-2114, USA |
| DARPA Contact Page | https://www.darpa.mil/contact |